Known targets — ChEMBL curated mechanism
ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3CHRM1CHRM2CHRM3CHRM4ESR1ESR2GABRA1GABRB1GABRG2GBA1HRH1HTR1DHTR2AOPRD1OPRK1OPRM1SLC6A2SLC6A3TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Cadaverine Tartrate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 known ✓ | P35372 | 1/20 | 0.54 |
| ▸ | GABRA1 known ✓ | P14867 | 2/20 | 0.45 |
| ▸ | GABRB1 known ✓ | P18505 | 2/20 | 0.45 |
| ▸ | GABRG2 known ✓ | P18507 | 2/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.48 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.48 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 2/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.45 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.45 |
| ▸ | GABRP | O00591 | 2/20 | 0.45 |
| ▸ | GABRD | O14764 | 2/20 | 0.45 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.45 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.45 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.45 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.45 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.45 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bicarbonate SCHEMBL6548682 | 0.87 | OPRM1 (0.64) | OPRM1TP53SLC1A2SLC1A1SLC1A3 | |
| Acetic Acid SCHEMBL5571311 | 0.85 | OPRM1 (0.61) | OPRM1TP53SLC1A2SLC1A1SLC1A3 | |
| Oxalic Acid SCHEMBL28713733 | 0.85 | OPRM1 (0.61) | OPRM1TP53SLC1A2SLC1A1SLC1A3 | |
| Oxalic Acid SCHEMBL28713732 | 0.85 | OPRM1 (0.61) | OPRM1TP53SLC1A2SLC1A1SLC1A3 | |
| Lactic Acid SCHEMBL5574449 | 0.82 | OPRM1 (0.64) | OPRM1TP53SLC1A2SLC1A1GPR84 | |
| SCHEMBL10310671 | 0.81 | SLC1A2 (0.50) | TP53SLC1A2SLC1A1SLC1A3CA2 | |
| SCHEMBL8016824 | 0.81 | SLC1A2 (0.50) | TP53SLC1A2SLC1A1SLC1A3CA2 | |
| SCHEMBL8283884 | 0.81 | SLC1A2 (0.50) | TP53SLC1A2SLC1A1SLC1A3CA2 | |
| Tuaminoheptane SCHEMBL25287775 | 0.80 | OPRM1 (0.76) | OPRM1TP53SLC1A2SLC1A1GPR84 | |
| Tuaminoheptane SCHEMBL3365884 | 0.80 | OPRM1 (0.76) | OPRM1TP53SLC1A2SLC1A1GPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080194696-A1 | Novel Arylbicyclo[3.1.0]Hexylamines And Methods And Compositions For Their Preparation And Use | ETHISMOS RESEARCH, INC. | 2008-08-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080194696-A1 | Novel Arylbicyclo[3.1.0]Hexylamines And Methods And Compositions For Their Preparation And Use | HTR2C, HTR1B, HTR3C | OPRM1 91/4885GABRA1 252/4885GABRB1 213/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.